Michigan Institute of Neurological Disorders

Farmington Hills, Michigan 48334

0 studies enrolling now · 1 studies all time

What they study most

Relapse-Remitting Multiple Sclerosis

Studies at this site

• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose — Completed